TNSN98175A1 - Implant contenant un parasiticide, et procede pour sa production - Google Patents

Implant contenant un parasiticide, et procede pour sa production

Info

Publication number
TNSN98175A1
TNSN98175A1 TNTNSN98175A TNSN98175A TNSN98175A1 TN SN98175 A1 TNSN98175 A1 TN SN98175A1 TN TNSN98175 A TNTNSN98175 A TN TNSN98175A TN SN98175 A TNSN98175 A TN SN98175A TN SN98175 A1 TNSN98175 A1 TN SN98175A1
Authority
TN
Tunisia
Prior art keywords
production
implant
parasiticide
implant containing
compound
Prior art date
Application number
TNTNSN98175A
Other languages
English (en)
French (fr)
Inventor
Huatan Hiep
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of TNSN98175A1 publication Critical patent/TNSN98175A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
TNTNSN98175A 1997-09-23 1998-09-22 Implant contenant un parasiticide, et procede pour sa production TNSN98175A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
TNSN98175A1 true TNSN98175A1 (fr) 2005-03-15

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN98175A TNSN98175A1 (fr) 1997-09-23 1998-09-22 Implant contenant un parasiticide, et procede pour sa production

Country Status (13)

Country Link
EP (1) EP1014970A1 (es)
JP (1) JP2001517622A (es)
AP (1) AP9801350A0 (es)
AR (1) AR013509A1 (es)
AU (1) AU9742298A (es)
BR (1) BR9812385A (es)
CA (1) CA2304283A1 (es)
GT (1) GT199800149A (es)
MA (1) MA24655A1 (es)
PA (1) PA8459501A1 (es)
PE (1) PE117199A1 (es)
TN (1) TNSN98175A1 (es)
WO (1) WO1999015166A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
AU1556000A (en) * 1999-11-22 2001-06-04 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602401A0 (en) 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
WO2018226512A1 (en) * 2017-06-06 2018-12-13 Merck Sharp & Dohme Corp. Long-action implant for treatment of infectious diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
PA8459501A1 (es) 2000-05-24
GT199800149A (es) 2000-03-15
PE117199A1 (es) 1999-11-20
AR013509A1 (es) 2000-12-27
MA24655A1 (fr) 1999-04-01
JP2001517622A (ja) 2001-10-09
WO1999015166A1 (en) 1999-04-01
AP9801350A0 (en) 2000-03-17
AU9742298A (en) 1999-04-12
BR9812385A (pt) 2000-09-12
EP1014970A1 (en) 2000-07-05
CA2304283A1 (en) 1999-04-01

Similar Documents

Publication Publication Date Title
TNSN98175A1 (fr) Implant contenant un parasiticide, et procede pour sa production
HU9600299D0 (en) Substituted azadioxacycloalkenes, fungicidal compositions containing them, process for the preparation of the compounds and the fungicidal compositions and method for combating fungi
PL348355A1 (en) Fungicidal active substance combinations
TNSN99053A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
AU5106996A (en) Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix and active agent preparations obtained thereby
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
AU6738696A (en) Halobenzimidazoles and their use as microbicides
HUT67924A (en) Fungicidal compositions containing 2-(substituted phenyl)-3-methoxy-propenecarboxylates as active ingredients, process for producing the active ingredients, and method for combatting fungi
BR9909332A (pt) Método & produto de tratamento de água
YU23102A (sh) Jedinjenja za lečenje ishemije
FR2780403B3 (fr) Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
FR2764887B1 (fr) Melange de diphenylamines nonylees, procede pour le preparer et composition le contenant
CY2461B1 (en) Polymorphic compounds.
ZA959451B (en) 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
ES2188011T3 (es) Agente de contraste para la reproduccion en imagenes de infartos y necrosis.
TNSN00106A1 (fr) Composition pharmaceutique nouvelle comprenant un inhibiteur de nos, et procede pour sa preparation
EP1420066A3 (en) Use of fullerene derivatives as DNA compaction agent
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
CA2321683A1 (en) Additives to chlorine dioxide bleaching
MA23194A1 (fr) Procede pour la preparation de particules preparees a sec, particules preparees a sec ainsi obtenues et compositions pharmaceutiques contenant de telles particules .
FR2851734B1 (fr) Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
TW360493B (en) Fungicidal mixtures and a method of controlling fungi using the same
TW200501970A (en) Use of PVP-iodine liposomes for treatment of acne
AU3031297A (en) N-sulfonylimidazoles used as fungicides
MXPA04006040A (es) Composicion con filtro solar que comprende clorfenesina.